APOQUEL Comprimé

国家: 加拿大

语言: 法文

来源: Health Canada

现在购买

下载 资料单张 (PIL)
22-04-2020

有效成分:

OCLACITINIB (Acide d'oclacitinib malique)

可用日期:

ZOETIS CANADA INC

剂量:

16MG

药物剂型:

Comprimé

组成:

OCLACITINIB (Acide d'oclacitinib malique) 16MG

给药途径:

Orale

每包单位数:

15G/50G

处方类型:

Prescription

治疗组:

Chiens

產品總結:

Numéro de groupe d'ingrédients actifs (GIA) :0155910003

授权状态:

APPROUVÉ

授权日期:

2014-07-09

资料单张

                                Apoquel
Labelling
April 16, 2020
EXTENDED LABEL - 3.6 MG, 5.4 MG AND 16 MG TABLETS - 20 OR 100 COUNT
BOTTLES
Note that the net contents are interchangeable (there is one bottle
size only for all strengths and
count bottles).
3.6 MG STRENGTH
Apoquel
Labelling
April 16, 2020
5.4 MG STRENGTH
Apoquel
Labelling
April 16, 2020
16 MG STRENGTH
Apoquel
Labelling
April 16, 2020
PACKAGE INSERT (part of the extended label and applicable to all
strengths)
DIN 02427885
DIN 02427893
DIN 02427907
APOQUEL
TM
oclacitinib tablets
VETERINARY USE ONLY
JANUS KINASE INHIBITOR FOR DOGS
DESCRIPTION: APOQUEL
TM
(oclacitinib maleate) is a synthetic Janus Kinase inhibitor. The
chemical name of the active ingredient in
APOQUEL tablets is N-methyl[trans-4-(methyl-7H-
pyrrolo[2,3-d]pyrimidin-4-ylamino) cyclohexyl]methanesulfonamide
(2Z)-2-butenedioate.
The chemical structure of oclacitinib maleate is:
INDICATIONS: For the control of pruritus associated with allergic
dermatitis and for the control of
atopic dermatitis in dogs at least 12 months of age.
DOSAGE AND ADMINISTRATION: The dose of APOQUEL tablets is 0.4 mg/kg to
0.6 mg oclacitinib
/kg body weight, administered orally, twice daily for up to 14 days,
and then administered once
daily for maintenance therapy. APOQUEL tablets may be administered
with or without food.
DOSING CHART
DOG BODY WEIGHT
(KG)
3.6 MG TABLETS
5.4 MG TABLETS
16 MG TABLETS
3 – 4.4
0.5
4.5 – 5.9
0.5
6 – 8.9
1
9 – 13.4
1
13.5 – 19.9
0.5
20 – 26.9
2
27 – 39.9
1
40 – 54.9
1.5
55 – 80
2
Apoquel
Labelling
April 16, 2020
CONTRAINDICATIONS:
APOQUEL tablets should not be given to dogs with known or suspected
allergy or intolerance to
oclacitinib maleate or any other components of this product.
APOQUEL tablets are not for use in dogs less than 12 months of age
(see ANIMAL SAFETY).
APOQUEL tablets are not for use in dogs with serious infections,
evidence of immune
suppression or evidence of malignant neoplasia.
APOQUEL tablets are not for use in breeding dogs, pregnant or
lactating bitches.
CAUTIONS:
The safe us
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 英文 22-04-2020

搜索与此产品相关的警报